Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07222722 · ClinicalTrials.gov registry record · NA
NIRS Monitoring in the NICU and AKI
A NA study of Acute Kidney Injury (AKI) and Postnatal AKI, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07222722 is a NA study of Acute Kidney Injury (AKI) and Postnatal AKI that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 100 participants, below the 4,613-participant average among 4 other Acute Kidney Injury (AKI) trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07222722, a NA study of Acute Kidney Injury (AKI) and Postnatal AKI, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants \<30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney injury (AKI) in premature infants \<30 weeks gestational age. The investigators will also compare various rates of complications including death, length-of-stay, and prolonged duration of mechanical ventilation, among others.
Conditions Studied
Interventions
- DEVICE NIRS Monitoring
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-11 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07222722
The ClinicalTrials.gov registry entry for NCT07222722 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,613-participant average among 4 other Acute Kidney Injury (AKI) trials with a reported enrollment target (98% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Kidney Injury (AKI) appearing as the primary indexed condition, and to 1 intervention - of which NIRS Monitoring is the first listed.
NCT07222722 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07222722 about?
NCT07222722 is a clinical study titled "NIRS Monitoring in the NICU and AKI". The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants \<30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney ...
What is the current status of trial NCT07222722?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-11. Estimated completion is 2026-04-01.
What conditions does trial NCT07222722 study?
This clinical trial studies the following conditions: Acute Kidney Injury (AKI), Postnatal AKI.
What interventions are being tested in trial NCT07222722?
The interventions under investigation include: NIRS Monitoring (DEVICE).
Who is sponsoring clinical trial NCT07222722?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07222722 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury (AKI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
RECRUITING · Phase 3
-
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
RECRUITING · Phase 4
-
Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery
COMPLETED · Phase 2
-
Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.